Medtronic links 780G insulin pump to benefits in kids as it works to grow sales

Due to regulatory issues at its diabetic section, Medtronic's MiniMed 780G insulin pump took longer than anticipated to receive U.S. clearance, taking place in April. The company is now turning on the gadget to help it recover from a four-year decline in diabetes business revenues and take market share away from competitors like Insulet and Tandem Diabetes Care. The American Diabetes Association (ADA) Scientific Sessions have been used by Medtronic to demonstrate how their recently approved MiniMed 780G pump can enhance the management of diabetes in kids. The results of a short clinical research were presented at the event by Medtronic, which revealed that adolescents using the pump can improve blood glucose management without carefully measuring carbohydrates.